Literature DB >> 17586086

Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis.

Jen Chang1, Julia J Hoy, Prema S Idumalla, Matthew S Clifton, Norman C Pecoraro, Aditi Bhargava.   

Abstract

It is becoming increasingly evident that the urocortins (Ucns) and their receptors are involved in the initiation and development of inflammation in the gastrointestinal (GI) tract. There has not been a systematic study of the basal expression of Ucns or their receptors in the GI tract. Here, we examined basal expression of Ucn 2 and its high-affinity receptor, CRF-R2 in the rat GI tract. Ucn 2 mRNA was expressed throughout the small and large intestine. Surprisingly, CRF-R2 mRNA expression was detected in only a subset of GI regions that expressed Ucn 2. Immunohistochemical study showed that both Ucn 2 immuno-reactivity (Ucn 2-IR) and CRF-R2-IR were consistently seen in the neurons of the myenteric plexus and the nerve fibers innervating the circular muscle. By and large, Ucn 2-IR was detected in all layers, including the mucosal and the submucosal layers throughout the GI regions. In contrast, CRF-R2-IR was very low or undetectable in the mucosal layers of all regions examined. The role of Ucn 2 and CRF-R2 was then examined in a rat model of chemically-induced colitis. In the early phase of colitis, Ucn 2 mRNA levels peaked, whereas, in striking contrast, CRF-R2 mRNA expression decreased approximately 2.5-fold below control levels. At the peptide level, Ucn 2-IR was specifically induced in a large population of immune cells that infiltrated the lamina propria and submucosa of the distal colon, whereas CRFR2-IR was detected in only a small fraction of infiltrated immune cells. CRF-R2-IR was dramatically reduced in the neurons of the myenteric plexus. Thus, we show, for the first time, that in the acute phase of inflammation, Ucn 2 levels are increased whereas expression levels of its only identified receptor, CRF-R2, are decreased. This suggests that Ucn 2 exerts its effects only in part via CRF-R2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586086      PMCID: PMC3718314          DOI: 10.1016/j.peptides.2007.05.008

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

Review 1.  Corticotropin releasing factor receptors and their ligand family.

Authors:  M H Perrin; W W Vale
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

Review 2.  Urocortins and the regulation of gastrointestinal motor function and visceral pain.

Authors:  Vicente Martinez; Lixin Wang; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2004-10       Impact factor: 3.750

3.  Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.

Authors:  Mulugeta Million; Céline Maillot; Paul Saunders; Jean Rivier; Wylie Vale; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-01       Impact factor: 4.052

Review 4.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

5.  Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease.

Authors:  E Gonzalez-Rey; A Fernandez-Martin; A Chorny; M Delgado
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

6.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.

Authors:  J Vaughan; C Donaldson; J Bittencourt; M H Perrin; K Lewis; S Sutton; R Chan; A V Turnbull; D Lovejoy; C Rivier
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

7.  Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies.

Authors:  Ekaterini Chatzaki; Brian J Murphy; Lixin Wang; Mulugeta Million; Gordon V Ohning; Paul D Crowe; Robert Petroski; Yvette Taché; Dimitri E Grigoriadis
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

8.  CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon.

Authors:  Ekaterini Chatzaki; Paul D Crowe; Lixin Wang; Mulugeta Million; Yvette Taché; Dimitri E Grigoriadis
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

9.  Urocortin in human gastric mucosa: relationship to inflammatory activity.

Authors:  E Chatzaki; I Charalampopoulos; C Leontidis; I A Mouzas; M Tzardi; C Tsatsanis; A N Margioris; A Gravanis
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes.

Authors:  K Suzuki; H Ota; S Sasagawa; T Sakatani; T Fujikura
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

View more
  32 in total

1.  Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation.

Authors:  Burcu Hasdemir; Pallavi Mhaske; Sreenivasan Paruthiyil; Elizabeth A Garnett; Melvin B Heyman; Mehrdad Matloubian; Aditi Bhargava
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

2.  Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.

Authors:  Eunok Im; Sang Hoon Rhee; Yong Seek Park; Claudio Fiocchi; Yvette Taché; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2010-03-03       Impact factor: 22.682

Review 3.  Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors:  M Larauche; C Kiank; Y Tache
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

4.  Corticotropin-releasing factor receptor 2 mediates sex-specific cellular stress responses.

Authors:  Eric Kubat; Shilpi Mahajan; Min Liao; Larry Ackerman; Peter T Ohara; Eileen F Grady; Aditi Bhargava
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

5.  Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon.

Authors:  Sumei Liu; W Ren; M-H Qu; G A Bishop; G-D Wang; X-Y Wang; Y Xia; J D Wood
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

6.  Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.

Authors:  Ekaterini Chatzaki; Peter A Anton; Mulugeta Million; Maria Lambropoulou; Theodoros Constantinidis; George Kolios; Yvette Taché; Dimitri E Grigoriadis
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.

Authors:  Shilpi Mahajan; Min Liao; Paris Barkan; Kazuhiro Takahashi; Aditi Bhargava
Journal:  Peptides       Date:  2014-01-22       Impact factor: 3.750

Review 8.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

9.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

10.  Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.

Authors:  Yoshikazu Kubo; Aiko Kumano; Kohei Kamei; Kikuko Amagase; Naoko Abe; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2009-08-26       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.